Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascular endothelial cells
Abstract Background Our previous study demonstrated that M1 macrophages could impair tight junctions (TJs) between vascular endothelial cells by secreting interleukin-6 (IL-6) after spinal cord injury (SCI). Tocilizumab, as a humanized IL-6 receptor (IL-6R) monoclonal antibody approved for the clini...
Main Authors: | Yang Luo, Fei Yao, Yi Shi, Zhenyu Zhu, Zhaoming Xiao, Xingyu You, Yanchang Liu, Shuisheng Yu, Dasheng Tian, Li Cheng, Meige Zheng, Juehua Jing |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12987-022-00399-9 |
Similar Items
-
Moderate systemic therapeutic hypothermia is insufficient to protect blood-spinal cord barrier in spinal cord injury
by: Rubing Zhou, et al.
Published: (2022-11-01) -
Pathological hemodynamic changes and leukocyte transmigration disrupt the blood–spinal cord barrier after spinal cord injury
by: Rubing Zhou, et al.
Published: (2023-05-01) -
Fascin-1 is Highly Expressed Specifically in Microglia After Spinal Cord Injury and Regulates Microglial Migration
by: Shuisheng Yu, et al.
Published: (2021-09-01) -
Spinal cord regeneration
by: Gourishankar Patnaik
Published: (2010-06-01) -
Jmjd3 mediates blood–spinal cord barrier disruption after spinal cord injury by regulating MMP-3 and MMP-9 expressions
by: Jee Y. Lee, et al.
Published: (2016-11-01)